Skip to main content
. Author manuscript; available in PMC: 2020 May 15.
Published in final edited form as: Neuropharmacology. 2019 Feb 13;150:217–228. doi: 10.1016/j.neuropharm.2019.02.010

Fig. 4.

Fig. 4.

Sedative effects of MP1104. (A) Effects of MP1104 (0.3, 0.6 & 1 mg/kg, i.p.) on ambulatory counts during and following habituation are shown over time (One-way ANOVA). (B) MP1104 (0.3 & 0.6 mg/kg, i.p.) showed non-significant decrease in ambulatory counts compared to vehicle treatment during the treatment testing time (60 min). One-way ANOVA. *p < 0.05 compared to the vehicle. Values presented as mean ± SEM, n = 8 per group.